The May 16 event will highlight the secular dynamics underpinning the decade of growth ahead
WILMINGTON, Delaware, April 12, 2022–(BUSINESS WIRE)–The Chemours Company (“Chemours”) (NYSE: CC), a global chemical company with market-leading positions in titanium technologies, thermal and specialty solutions, advanced performance materials and chemical solutions , announced today that it will host an investor webinar on May 16, 2022 at 10 a.m. Eastern Daylight Time. The event will focus on the Thermal and Specialty Solutions segment highlighting secular dynamics, key business drivers and strategic growth initiatives. Presenters will include Mark Newman, President and CEO, Alisha Bellezza, President Thermal and Specialty Solutions, and Jonathan Lock, Senior Vice President and Chief Development Officer.
The event is open to the public and can be viewed via live webcast on the Chemours Investor Relations website, or via this link.
This event will also be accessible by teleconference by dialing 833-502-0453; Conference ID: 2376625 (in the US) or +1-778-560-2539; Conference ID: 2376625 (outside the United States).
A replay of the webcast will be available after the presentation via this link.
About Chemours Company
The Chemours Company (NYSE: CC) is a global leader in titanium technologies, thermal and specialty solutions, advanced performance materials and chemical solutions, providing customers with solutions across a wide range of industries with products that define the market, application expertise and chemistry. based innovations. We offer custom solutions with a wide range of industrial and specialty chemicals for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, general industrial , oil and gas. Our flagship products include renowned brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™ and Krytox™. The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,200 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to historical or current fact. The words “believe”, “expect”, “will”, “anticipate”, “plan”, “estimate”, “target”, “project” and similar expressions, among others, generally identify “forward-looking statements who speak only as of the date these statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any outstanding or future environmental liabilities, the commencement, outcome or resolution of any investigation, inquiry or regulatory proceeding, the initiation , the outcome or settlement of any litigation, changes in environmental regulations in the United States or other jurisdictions that affect the demand for or adoption of our products, the expected future operational and financial performance of our segments individually and our company as a whole, business plans, outlook, targets, objectives and commitments, capital investments and projects and target capital expenditures, dividend or share buyback plans , sufficiency or longevity of intellectual property protection, cost reduction or savings targets, plans for increasing profitability and he growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, which are subject to substantial risks and uncertainties that could cause results actual results differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties beyond Chemours’ control. Additionally, the current COVID-19 pandemic has had a significant impact on the national and global economy as well as commodity and financial markets, which has had and we expect will continue to have an impact. negative on our financial results. The extent and impact of the pandemic is still being determined and to date has included significant financial and commodity market volatility and severe disruption to economic activity. The public and private sector response has resulted in travel restrictions, temporary business closures, quarantines, stock market volatility, and disruptions to consumer and commercial activities around the world. Matters beyond our control have affected our business and operations and may or may continue to impair our ability to provide goods and services to customers, disrupt our supply chains, harm our business partners, significantly reduce demand for our products, to the health and welfare of our staff or cause other unforeseeable events. In addition, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the United States Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2021. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220412005863/en/
SVP, Director of Development and Investor Relations
Manager, Investor Relations
Head of media relations and financial communication